Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Role of Vitamins in Maintaining Bone Health

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Normal Routine Spirometry Can Mask COPD/Emphysema in Symptomatic Smokers.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2021

Same author

Small airway loss in the physiologically ageing lung: a cross-sectional study in unused donor lungs.

The Lancet. Respiratory medicine·2020

Same author

Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.

The Lancet. Respiratory medicine·2020

Same author

Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD.

Thorax·2018

Same author

Teamwork and Adherence to Recommendations Explain the Effect of a Care Pathway on Reduced 30-day Readmission for Patients with a COPD Exacerbation.

COPD·2018

Same author

A simple algorithm for the identification of clinical COPD phenotypes.

The European respiratory journal·2017

Search research articles

Related Experiment Videos

COPD, bone metabolism, and osteoporosis.

An Lehouck¹, Steven Boonen², Marc Decramer¹

¹Respiratory Division, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.

|March 3, 2011

Summary

Chronic obstructive pulmonary disease (COPD) and osteoporosis share risk factors, leading to increased fracture risk. Early osteoporosis prevention and treatment in COPD patients are crucial for better outcomes.

Related Experiment Videos

Area of Science:

Pulmonology and Endocrinology
Gerontology and Bone Metabolism

Background:

Chronic obstructive pulmonary disease (COPD) and osteoporosis frequently coexist due to shared risk factors like aging, smoking, and physical inactivity.
Systemic inflammation, vitamin D deficiency, and corticosteroid use in COPD exacerbate bone loss, increasing osteoporosis risk.
Osteoporosis in COPD patients can lead to fragility fractures, worsening mobility, and increasing morbidity and mortality.

Purpose of the Study:

To highlight the significant association between COPD and osteoporosis.
To emphasize the importance of early prevention and treatment of osteoporosis in COPD patients.
To recommend integrated risk assessment tools for managing bone health in COPD.

Main Methods:

Review of common risk factors and pathophysiological mechanisms linking COPD and osteoporosis.
Discussion of the impact of osteoporosis-related fractures on COPD patients.
Evaluation of risk assessment tools like FRAX for integrated assessment.

Main Results:

COPD and osteoporosis share common risk factors and pathophysiological pathways.
Fractures in COPD patients significantly impair mobility and increase mortality.
Integrated risk assessment tools are essential for managing osteoporosis in COPD.

Conclusions:

Integrated risk assessment and management are vital for preventing and treating osteoporosis in COPD patients.
Existing osteoporosis treatment guidelines should be rigorously applied in COPD management.
Further research focusing on bone health interventions in COPD is warranted.